Publicacións nas que colabora con FERNANDO ESCOBAR JIMÉNEZ (17)

2012

  1. Impact of a 'school-based' nutrition intervention on anthropometric parameters and the metabolic syndrome in Spanish adolescents

    Annals of Nutrition and Metabolism, Vol. 61, Núm. 4, pp. 281-288

2008

  1. Effects of raloxifene therapy on circulating osteoprotegerin and RANK ligand levels in post-menopausal osteoporosis

    Journal of Endocrinological Investigation, Vol. 31, Núm. 5, pp. 416-421

  2. Effects of risedronate on metabolic bone disease in patients with type 1 diabetes and osteoporosis

    Revista Española de Enfermedades Metabólicas Oseas, Vol. 17, Núm. 4, pp. 66-70

2005

  1. The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women

    Osteoporosis International, Vol. 16, Núm. 11, pp. 1368-1374

2003

  1. Performance of quantitative ultrasound in the discrimination of prevalent osteoporotic fractures in a bone metabolic unit

    Bone, Vol. 32, Núm. 5, pp. 571-578

2002

  1. Performance of COLIA1 polymorphism and bone turnover markers to identify postmenopausal women with prevalent vertebral fractures

    Osteoporosis International, Vol. 13, Núm. 6, pp. 506-512

  2. Prevalence of vitamin D deficiency in populations at risk for osteoporosis: Impact on bone integrity

    Medicina Clinica, Vol. 119, Núm. 3, pp. 85-89

2001

  1. Bone mineral density at time of clinical diagnosis of adult-onset type 1 diabetes mellitus

    Endocrine Practice, Vol. 7, Núm. 5, pp. 346-351

  2. Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women

    Journal of Bone and Mineral Research, Vol. 16, Núm. 8, pp. 1408-1415

  3. The contribution of IGF-I to skeletal integrity in postmenopausal women

    Clinical Endocrinology, Vol. 55, Núm. 6, pp. 759-766

2000

  1. Factors associated with microalbuminuria in Type 1 diabetes mellitus: A cross-sectional study

    Diabetes Research and Clinical Practice, Vol. 48, Núm. 1, pp. 43-49

1997

  1. Antiresorptive Therapy in Hyperthyroid Patients: Longitudinal Changes in Bone and Mineral Metabolism

    Journal of Clinical Endocrinology and Metabolism, Vol. 82, Núm. 6, pp. 1989-1994

  2. Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: Influence of aetiology and menopause

    Clinical Endocrinology, Vol. 47, Núm. 3, pp. 279-285

  3. Identification of metabolic bone disease in patients with endogenous hyperthyroidism: Role of biological markers of bone turnover

    Calcified Tissue International, Vol. 61, Núm. 5, pp. 370-376

  4. Reclassification after delivery of diabetes in pregnancy

    Annali dell'Istituto Superiore di Sanita, Vol. 33, Núm. 3, pp. 323-327

1996

  1. Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus

    Calcified Tissue International, Vol. 58, Núm. 5, pp. 316-319

1995

  1. Comparison of fluoxetine and placebo in the treatment of obesity

    Annals of Nutrition and Metabolism, Vol. 39, Núm. 3, pp. 159-163